ProMIS Neurosciences, Inc. (PMN)
EBITDA Growth
-201.07%
TTM · Period ending:
PMN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-201.07%period ending
Latest reported-201.07%period ending
PMN TTM EBITDA YoY % (-192.46% → -201.07%)
Year-over-year change
High-resolution chart · PNG
PMN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -201.072% | |
| -513.8111% | |
| -1,268.9507% | |
| -4,494.815% | |
| -15.1587% | |
| 47.2412% | |
| 81.6414% | |
| 96.4925% | |
| 55.3875% | |
| 54.6326% | |
| 33.175% | |
| -35.1816% | |
| -207.5038% | |
| -389.0641% | |
| -494.0663% | |
| -536.3837% | |
| -196.2074% | |
| -24.7944% | |
| 29.3259% | |
| 60.6311% | |
| 50.2391% | |
| 21.7604% | |
| 13.8215% | |
| 25.7014% | |
| 36.9015% | |
| 40.9669% | |
| 24.5033% | |
| -44.5057% | |
| -92.0233% | |
| -106.5184% | |
| -87.5077% | |
| -28.6408% | |
| -25.7689% | |
| -55.8318% | |
| -80.1949% | |
| -114.0015% | |
| -95.4134% | |
| -79.941% | |
| -68.9236% | |
| -37.929% | |
| -22.2322% | |
| 27.8677% | |
| 45.8503% | |
| 41.5619% | |
| 33.4293% | |
| -9.6239% | |
| -38.9941% | |
| -27.9104% | |
| -12.8746% | |
| 3.009% | |
| 14.5407% | |
| 18.0517% | |
| 12.6424% | |
| 10.2032% | |
| 9.5467% | |
| 4.9228% | |
| -24.1097% | |
| 17.7377% | |
| 24.2593% | |
| 27.3009% | |
| 58.7821% | |
| 32.3881% | |
| 16.7414% | |
| 3.7803% | |
| -33.7512% | |
| -4.4936% | |
| 16.1495% | |
| 32.3276% | |
| 44.0898% | |
| 36.9405% | |
| 26.9759% | |
| 3.9509% | |
| -43.367% | |
| -84.7158% | |
| -160.5466% | |
| -162.9531% | |
| -157.0516% | |
| -192.4556% |